Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2371 AL 2385

Concise review: Patient-derived olfactory stem cells: new models for brain diseases

Mackay-Sim A.

Stem Cells. 2012 Nov;30(11):2361-5. doi: 10.1002/stem.1220.

The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants

Sanatani S, Potts JE, Reed JH, Saul JP, Stephenson EA, Gibbs KA, Anderson CC, Mackie AS, Ro PS, Tisma-Dupanovic S, Kanter RJ, Batra AS, Fournier A, Blaufox AD, Singh HR, Ross BA, Wong KK, Bar-Cohen Y, McCrindle BW, Etheridge SP.

Circ Arrhythm Electrophysiol. 2012 Oct;5(5):984-91. doi: 10.1161/CIRCEP.112.972620. Epub 2012 Sep 8.

The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases

Lescaudron L, Naveilhan P, Neveu I.

Curr Med Chem. 2012;19(35):6018-35.

Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population

Balafkan N, Tzoulis C, Müller B, Haugarvoll K, Tysnes OB, Larsen JP, Bindoff LA.

Mitochondrion. 2012 Nov;12(6):640-3. doi: 10.1016/j.mito.2012.08.004. Epub 2012 Aug 29.

Effect of subthalamic deep brain stimulation on pain in Parkinson's disease

Dellapina E, Ory-Magne F, Regragui W, Thalamas C, Lazorthes Y, Rascol O, Payoux P, Brefel-Courbon C.

Pain. 2012 Nov;153(11):2267-2273. doi: 10.1016/j.pain.2012.07.026. Epub 2012 Sep 7.

Parasomnias: an updated review

Howell MJ.

Neurotherapeutics. 2012 Oct;9(4):753-75. doi: 10.1007/s13311-012-0143-8.

Associations of welding and manganese exposure with Parkinson disease: review and meta-analysis

Mortimer JA, Borenstein AR, Nelson LM.

Neurology. 2012 Sep 11;79(11):1174-80. doi: 10.1212/WNL.0b013e3182698ced.

Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis

Moteshafi H, Zhornitsky S, Brunelle S, Stip E.

Drug Saf. 2012 Oct 1;35(10):819-36. doi: 10.1007/BF03261978.

Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse

Perfeito R, Cunha-Oliveira T, Rego AC.

Free Radic Biol Med. 2012 Nov 1;53(9):1791-806. doi: 10.1016/j.freeradbiomed.2012.08.569. Epub 2012 Aug 25.

[Antidepressants for treatment of depression in palliative patients : a systematic literature review]

Ujeyl M, Müller-Oerlinghausen B.

Schmerz. 2012 Sep;26(5):523-36. doi: 10.1007/s00482-012-1221-x.

Transcriptome analysis of a rotenone model of parkinsonism reveals complex I-tied and -untied toxicity mechanisms common to neurodegenerative diseases

Cabeza-Arvelaiz Y, Schiestl RH.

PLoS One. 2012;7(9):e44700. doi: 10.1371/journal.pone.0044700. Epub 2012 Sep 7.

[REM sleep behavior disorder (RBD)]

Ylikoski A, Partinen M.

Duodecim. 2012;128(15):1602-6.

Considerations for measuring iron in post-mortem tissue of Parkinson's disease patients

Hare DJ, Gerlach M, Riederer P.

J Neural Transm (Vienna). 2012 Dec;119(12):1515-21. doi: 10.1007/s00702-012-0898-4. Epub 2012 Sep 13.

[Case of acquired hepatocerebral degeneration with prominent improvement of parkinsonism and cognitive deficits after living-donor liver transplantation]

Ishihara T, Ito M, Watanabe H, Ishigami M, Kiuchi T, Sobue G.

Rinsho Shinkeigaku. 2012;52(8):581-4. doi: 10.5692/clinicalneurol.52.581.

The role of the right dorsolateral prefrontal cortex in the Tower of London task performance: repetitive transcranial magnetic stimulation study in patients with Parkinson's disease

Srovnalova H, Marecek R, Kubikova R, Rektorova I.

Exp Brain Res. 2012 Nov;223(2):251-7. doi: 10.1007/s00221-012-3255-9. Epub 2012 Sep 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias